← Leaderboards
Michael D Geschwind
University Of California San Francisco
$23,119,860
Attributed
$33,714,230
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,714,230 · 5
By mechanism
RF1$21,188,740 · 1
R01$11,123,514 · 2
R56$799,901 · 1
K23$602,075 · 1
Top collaborators
- Jane S Paulsen2 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Stanley B Prusiner$54,781,835
- R Kiplin Guy$13,409,185
- Nirao Mahesh Shah$25,020,886
- Fred E Cohen$5,735,573
- Michael A Baldwin$2,177,271
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposMagnetic Resonance ImagingEarly DiagnosisImageSymptomsCognitiveS DiseaseProgramsNeurodegenerative DisordersPrion DiseasesTreatment TrialCreutzfeldt-Jakob SyndromeBrainBiological MarkersClinical ResearchDementiaFamilyStagingCohortBehavioralNeurologicBaseFutureUnited States
Grant awards (24)
Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular disease$7,360,030
RF1 · FY2025 · AG
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)$1,086,202
R01 · FY2023 · AG · contact PI
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)$1,146,463
R01 · FY2022 · AG · contact PI
Unraveling the earliest phases of vascular cognitive impairment and dementia using CADASIL--a monogenic form of small vessel cerebrovascular disease$13,828,710
RF1 · FY2021 · AG
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)$1,186,626
R01 · FY2021 · AG · contact PI
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)$1,038,413
R01 · FY2020 · AG · contact PI
Tracking longitudinal change in presymptomatic genetic prion disease (TLC-Pre-gPrD)$962,633
R01 · FY2019 · AG · contact PI
TLC-Pre-gPrD: Tracking Longitudinal Change in Presymptomatic genetic Prion Disease$799,901
R56 · FY2018 · AG · contact PI
Predicting progression of human prion disease$586,201
R01 · FY2017 · AG · contact PI
Predicting progression of human prion disease$136,520
R01 · FY2017 · AG · contact PI
Predicting progression of human prion disease$605,336
R01 · FY2016 · AG · contact PI
Predicting progression of human prion disease$596,153
R01 · FY2015 · AG · contact PI
Predicting progression of human prion disease$624,529
R01 · FY2014 · AG · contact PI
Predicting progression of human prion disease$627,594
R01 · FY2013 · AG · contact PI
Early Diagnosis of Human Prion Disease$569,059
R01 · FY2012 · AG · contact PI
Early Diagnosis of Human Prion Disease$475,594
R01 · FY2011 · AG · contact PI
Early Diagnosis of Human Prion Disease$489,910
R01 · FY2010 · AG · contact PI
Early Diagnosis of Human Prion Disease$493,771
R01 · FY2009 · AG · contact PI
Early Diagnosis of Human Prion Disease$498,510
R01 · FY2008 · AG · contact PI
New Clinical Approaches to Creutzfeldt-Jakob Disease$121,770
K23 · FY2007 · AG · contact PI
New Clinical Approaches to Creutzfeldt-Jakob Disease$121,770
K23 · FY2006 · AG · contact PI
New Clinical Approaches to Creutzfeldt-Jakob Disease$121,770
K23 · FY2005 · AG
New Clinical Approaches to Creutzfeldt-Jakob Disease$119,733
K23 · FY2004 · AG
New Clinical Approaches to Creutzfeldt-Jakob Disease$117,032
K23 · FY2003 · AG